Delivery Order SPE2DB24D1021-SPE2DB25FEXEU
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,076.43 delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military...
- The Defense Logistics Agency awarded a $1,397.33 delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100 count) on June 17, 2025, with an ultimate completion date of June 18, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a Delivery Order valued at $7,765.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract specifies Conshohocken, Pennsylvania as the place of performance and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $13,377.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg on August 20, 2025, with completion targeted for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,450.92 for Vyvanse 20 mg capsules (quantity 100s) on April 21, 2025, with an ultimate completion date of April 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,139.08 for Vyvanse 10 mg capsules (100-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-competitive delivery order represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,940.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). The contract, with an ultimate completion date of September 4, 2025, was not set aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.54 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Vyvanse 70 mg capsules (100-count units). This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Vyvanse 50 mg capsules (quantity 100). This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, with no set-aside designation, indicating competitive award. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...